Moderate to severe tricuspid regurgitation (≥ 2/4) diagnosed with echocardiography in patients stabilized.
OtherModerate to severe tricuspid regurgitation (≥ 2/4) diagnosed with echocardiography in patients stabilized.
NCT Number: NCT03159923
The aim of this study is to improve the definition of the two main types of secondary tricuspid regurgitation.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Chu Amiens-Picardie - Site Sud, Amiens, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Moderate to severe tricuspid regurgitation (≥ 2/4) diagnosed with echocardiography in patients stabilized.
Time frame: through study completion, an average of 1 year
Rennes University Hospital
Other
Acronym: TRAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06699056
Arrhythmias, Cardiac, Atrial Enlargement
Orange, California, United States
View Trial DetailsNCT03745313
Cardiovascular Diseases, Deglutition Disorders
Los Angeles, California, United States
View Trial DetailsNCT02339974
Cardiovascular Diseases, Heart Diseases
Detroit, Michigan, United States
View Trial DetailsNCT06343363
Cardiovascular Diseases, Heart Diseases
Oxford, Oxfordshire, United Kingdom
View Trial Details